Page 14 - பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பார்க்கர் நிறுவனம் க்கு புற்றுநோய் நோயெதிர்ப்பு சிகிச்சை Today - Breaking & Trending Today

INOVIO Reports Fourth Quarter 2020 and Year-End Financial Results


Share this article
Share this article
PLYMOUTH MEETING, Pa., March 1, 2021 /PRNewswire/  INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today reported financial results for the quarter ended December 31, 2020. INOVIO s management will host a live conference call and webcast at 4:30 p.m. Eastern Standard Time today to discuss financial results and provide a general business update, including: top-line efficacy data from REVEAL 1, a Phase 3 clinical trial of VGX-3100; a progress update for the company s INNOVATE Phase 2/3 COVID-19 vaccine clinical trial and its development strategy regarding the new COVID-19 vaccine addressing the current and future COVID variants of concern (VOC); and a general update on its DNA medicines platform. The live webcast and a replay may be accessed by visiting INOVIO s website at http: ....

United States , Hong Kong , United Kingdom , South Africa , Macau General , South African , Ben Matone , Jeff Richardson , Kaneka Eurogentec , J Joseph Kim , Walter Reed Army Institute Of Research , Us Department Of Defense , National Cancer Institute , National Institute Of Allergy , Us Department Of Defense Do , Plumbline Life Sciences , Melinda Gates Foundation , Inovio Pharmaceuticals Inc , Coalition For Epidemic Preparedness Innovations , Society For Neuro , Defense Consortium , Parker Institute For Cancer Immunotherapy , International Vaccine Institute , Pharmaceuticals Inc , Nuclear Defense , Indiana University ,